BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986500 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986500\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06997029-11188@assetmemo.bio
DTSTAMP:20261121T005557Z
DTSTART;VALUE=DATE:20281214
DTEND;VALUE=DATE:20281215
SUMMARY:BMS-986500: Phase 1 readout est. (NCT06997029)
DESCRIPTION:BMS-986500\, phase 1\, Advanced Solid Tumors.\nStudy: A Phase 1
  Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Sol
 id Tumors\nEstimated primary completion: 14 December 2028. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/bms-986500#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT06997029
URL:https://assetmemo.bio/drug/bms-986500#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
